These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24684906)

  • 41. Toxic Activation of an AAA+ Protease by the Antibacterial Drug Cyclomarin A.
    Maurer M; Linder D; Franke KB; Jäger J; Taylor G; Gloge F; Gremer S; Le Breton L; Mayer MP; Weber-Ban E; Carroni M; Bukau B; Mogk A
    Cell Chem Biol; 2019 Aug; 26(8):1169-1179.e4. PubMed ID: 31204287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery, absolute assignments, and total synthesis of asperversiamides A-C and their potent activity against Mycobacterium marinum.
    Hou XM; Liang TM; Guo ZY; Wang CY; Shao CL
    Chem Commun (Camb); 2019 Jan; 55(8):1104-1107. PubMed ID: 30623956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Mycobacterium tuberculosis leucyl-tRNA synthetase (LeuRS) inhibitors among the derivatives of 5-phenylamino-2H-[1,2,4]triazin-3-one.
    Gudzera OI; Golub AG; Bdzhola VG; Volynets GP; Kovalenko OP; Boyarshin KS; Yaremchuk AD; Protopopov MV; Yarmoluk SM; Tukalo MA
    J Enzyme Inhib Med Chem; 2016; 31(sup2):201-207. PubMed ID: 27241561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids.
    Hicks RP
    Bioorg Med Chem; 2016 Sep; 24(18):4056-4065. PubMed ID: 27387357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pentapeptide boronic acid inhibitors of Mycobacterium tuberculosis MycP1 protease.
    Frasinyuk MS; Kwiatkowski S; Wagner JM; Evans TJ; Reed RW; Korotkov KV; Watt DS
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3546-8. PubMed ID: 24915878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and Structural Characterization of Naturally-Occurring Broad-Spectrum Cyclic Antibiotics Isolated from Paenibacillus.
    Knolhoff AM; Zheng J; McFarland MA; Luo Y; Callahan JH; Brown EW; Croley TR
    J Am Soc Mass Spectrom; 2015 Oct; 26(10):1768-79. PubMed ID: 26250559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trichormamides C and D, antiproliferative cyclic lipopeptides from the cultured freshwater cyanobacterium cf. Oscillatoria sp. UIC 10045.
    Luo S; Kang HS; Krunic A; Chen WL; Yang J; Woodard JL; Fuchs JR; Hyun Cho S; Franzblau SG; Swanson SM; Orjala J
    Bioorg Med Chem; 2015 Jul; 23(13):3153-62. PubMed ID: 26001342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria.
    Moreira W; Ngan GJ; Low JL; Poulsen A; Chia BC; Ang MJ; Yap A; Fulwood J; Lakshmanan U; Lim J; Khoo AY; Flotow H; Hill J; Raju RM; Rubin EJ; Dick T
    mBio; 2015 May; 6(3):e00253-15. PubMed ID: 25944857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neamphamide B, new cyclic depsipeptide, as an anti-dormant mycobacterial substance from a Japanese marine sponge of Neamphius sp.
    Yamano Y; Arai M; Kobayashi M
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4877-81. PubMed ID: 22704240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The unfoldase ClpC1 of
    Lunge A; Gupta R; Choudhary E; Agarwal N
    J Biol Chem; 2020 Jul; 295(28):9455-9473. PubMed ID: 32409584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibacterial activity of and resistance to small molecule inhibitors of the ClpP peptidase.
    Compton CL; Schmitz KR; Sauer RT; Sello JK
    ACS Chem Biol; 2013 Dec; 8(12):2669-77. PubMed ID: 24047344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis.
    Gustafsson TN; Osman H; Werngren J; Hoffner S; Engman L; Holmgren A
    Biochim Biophys Acta; 2016 Jun; 1860(6):1265-71. PubMed ID: 26971857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.
    Tam JP; Lu YA; Yang JL; Chiu KW
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8913-8. PubMed ID: 10430870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins.
    Kling A; Lukat P; Almeida DV; Bauer A; Fontaine E; Sordello S; Zaburannyi N; Herrmann J; Wenzel SC; König C; Ammerman NC; Barrio MB; Borchers K; Bordon-Pallier F; Brönstrup M; Courtemanche G; Gerlitz M; Geslin M; Hammann P; Heinz DW; Hoffmann H; Klieber S; Kohlmann M; Kurz M; Lair C; Matter H; Nuermberger E; Tyagi S; Fraisse L; Grosset JH; Lagrange S; Müller R
    Science; 2015 Jun; 348(6239):1106-12. PubMed ID: 26045430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of high throughput screening methods for inhibitors of ClpC1P1P2 from Mycobacteria tuberculosis.
    Fraga H; Rodriguez B; Bardera A; Cid C; Akopian T; Kandror O; Park A; Colmenarejo G; Lelievre J; Goldberg A
    Anal Biochem; 2019 Feb; 567():30-37. PubMed ID: 30543804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
    Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Planktocyclin, a cyclooctapeptide protease inhibitor produced by the freshwater cyanobacterium Planktothrix rubescens.
    Baumann HI; Keller S; Wolter FE; Nicholson GJ; Jung G; Süssmuth RD; Jüttner F
    J Nat Prod; 2007 Oct; 70(10):1611-5. PubMed ID: 17935298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery.
    Nautiyal A; Patil KN; Muniyappa K
    J Antimicrob Chemother; 2014 Jul; 69(7):1834-43. PubMed ID: 24722837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conformational Analysis of an Antibacterial Cyclodepsipeptide Active against Mycobacterium tuberculosis by a Combined ROE and RDC Analysis.
    Fredersdorf M; Kurz M; Bauer A; Ebert MO; Rigling C; Lannes L; Thiele CM
    Chemistry; 2017 Apr; 23(24):5729-5735. PubMed ID: 28106929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potent Bactericidal Antimycobacterials Targeting the Chaperone ClpC1 Based on the Depsipeptide Natural Products Ecumicin and Ohmyungsamycin A.
    Hawkins PME; Hoi DM; Cheung CY; Wang T; Quan D; Sasi VM; Liu DY; Linington RG; Jackson CJ; Oehlers SH; Cook GM; Britton WJ; Clausen T; Payne RJ
    J Med Chem; 2022 Mar; 65(6):4893-4908. PubMed ID: 35293761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.